19 transactions in one company, from January 9, 2025 to June 25, 2025.
Where this insider traded.
| Company | Ticker | Trades | Bought | Sold |
|---|---|---|---|---|
| Regulus Therapeutics Inc. | RGLS | 19 | $54K | $160K |
19 in total, newest filings first.
| Company | Ticker | Insider | Date | Code | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 2,976 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 1,350,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 990,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 249,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 1,312,500 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 100,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 30,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 160,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 90,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 100,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 1,000 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jun 25 | DReturned to issuer | 6,500 | — | — | 0derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEO | Jun 25 | DReturned to issuer | 571,558 | — | — | 0 |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEODERIV | Jan 30 | AAward | 1,350,000 | $0.00 | —? | 1,350,000derivatives |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEO | Jan 30 | P | 50,000 | $1.09 | $54K | 260,808 |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEO | Jan 14 | SPLAN | 11,764 | $1.26 | $15K | 210,808 |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEO | Jan 13 | SPLAN | 115,290 | $1.26 | $146K | 222,572 |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEO | Jan 9 | AAward | 62,000 | $1.30 | $81K | 337,862 |
| Regulus Therapeutics Inc. | RGLS | Joseph P. HaganCEO | Jan 9 | AAward | 218,750 | $1.36 | $298K | 275,862 |